Mangoceuticals, Inc.
MGRX
Revenue
163.16k
▼-50.93k▼-23.79%
3 Months ChangeAssets
15.24M
▲14.94M▲4954.89%
3 Months ChangeLiabilities
1.41M
▲148.47k▲11.78%
3 Months ChangeFree Cash Flow
-1.81M
▼-1.81M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043134
2024-10-25
Form 8-K
ID: 0001493152-24-042546
2024-10-22
Form 8-K
ID: 0001493152-24-041885
2024-10-21
Form 8-K
ID: 0001493152-24-041802
2024-10-11
Form 8-K
ID: 0001493152-24-040955
2024-10-03
Form 8-K
ID: 0001493152-24-039300
2024-10-02
Form 8-K
ID: 0001493152-24-039223
2024-10-01
Form 8-K
ID: 0001493152-24-038933
2024-09-27
Form 8-K
ID: 0001493152-24-038544
2024-08-23
Form 8-K
ID: 0001493152-24-033739